BAL PHARMA
Back to All Ratios
|
BAL PHARMA Last 5 Year EV/CE History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EV/CE(x) | 0.73 | 0.99 | 0.77 | 0.68 | 0.84 |
What is the latest EV/CE ratio of BAL PHARMA ?
Year | EV/CE |
---|---|
Mar2023 | 0.73 |
Mar2022 | 0.99 |
Mar2021 | 0.77 |
Mar2020 | 0.68 |
Mar2019 | 0.84 |
How is EV/CE of BAL PHARMA Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2023 | 0.73 | -26.26 | |
Mar2022 | 0.99 | 28.57 | |
Mar2021 | 0.77 | 13.24 | |
Mar2020 | 0.68 | -19.05 | |
Mar2019 | 0.84 | - |
Other Financial Ratios of BAL PHARMA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹155.8 Cr | -1.7% | -4.7% | 23.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹358,305.0 Cr | -1% | -7.2% | 56.8% | Stock Analytics | |
CIPLA | ₹109,709.0 Cr | -4.6% | -6.2% | 49.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹100,599.0 Cr | -4.1% | 1.1% | 19.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,073.3 Cr | -7.4% | -4.8% | 22.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,383.3 Cr | -2.9% | -3.9% | 94.8% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | -1.7% |
-4.7% |
23.7% |
SENSEX | -3% |
-2.5% |
17.3% |
You may also like the below Video Courses